A Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 13 Jun 2013
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Nov 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 19 Jan 2012 Planned end date changed from 1 Jun 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 03 May 2010 New trial record